AMANDA SZELTNER: Open Payments
NPI 1114403490 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 11 payments from 6 companies in 2025. Trend: 2023 $543 · 2024 $695 · 2025 $678
Food & beverage: $678
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 4 | $261 |
| Kite Pharma, Inc. | 3 | $218 |
| Janssen Biotech, Inc. | 1 | $86 |
| Celgene Corporation | 1 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Terumo BCT, Inc. | 1 | $14 |
Products named: Niktimvo, Yescarta, TALVEY, BREYANZI, NINLARO, SPECTRA OPTIA, JAKAFI.
Industry payments across LA — which companies pay providers there.
